July 13, 2009 - The Access to Medical Imaging Coalition (AMIC), today, echoed a key sentiment expressed by 40 House Democrats in a letter to the House Democratic leadership regarding regional disparities in Medicare reimbursement rates.

July 13, 2009 - On July 7 the American College of Radiology Imaging Network (ACRIN) started its first cardiovascular trial, ACRIN PA 4005 “Randomized Controlled Study of a Rapid 'Rule Out' Strategy Using CT Coronary Angiography Versus Traditional Care for Low-Risk ED Patients with Potential Acute Coronary Syndromes.”

July 13, 2009 - Purdue University researchers have developed a "homing device" for prostate cancer using by synthesizing a molecule that finds and penetrates prostate cancer cells and using imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.

July 13, 2009 - The new ProCure Proton Therapy Center in Oklahoma City celebrated its official grand opening on July 8, 2009, where patients with head and neck, brain, central nervous system, prostate and some pediatric cancers will be treated at the new Center

July 10, 2009 - Intelerad Medical Systems, an industry-leading PACS solution vendor, installed its InteleOne solution at Diversified Radiology of Colorado (DRC) to consolidate its image and patient data from multiple PACS and RIS systems into a streamlined, single workflow solution.

July 9, 2009 – According to Millennium Research Group (MRG), the ongoing economic crisis is putting pressure on publicly funded European healthcare systems, intensifying the decline of interventional cardiology device prices in the region.

July 6, 2009 – Royal Philips Electronics recently released the Veradius X-ray system, a mobile C-arm with a super thin, flat detector.

July 8, 2009 - The Susan G. Komen for the Cure, a leading breast cancer organization, is announcing millions of dollars in long-term grant funding for research on whether individuals can prevent development of their own cancers.

July 8, 2009 - Covidien said today Health Canada approved the company’s abbreviated new drug submission (ANDS) for its kit for the preparation of technetium Tc 99m Sestamibi injection. Covidien’s generic product is fully substitutable for Cardiolite, the company said.